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PROMOTING FOLLOW-UP IN PATIENTS
WITH NEW PRESCRIPTIONS FOR
SECOND-GENERATION
ANTIPSYCHOTICS
An Accessible Informational Pamphlet For Patients and Prescribers

OBHIJIT D HAZARIKA
Family Medicine Clerkship, Autumn 2019
Community Health Centers of Burlington – Riverside
Mentor: Adam R. Greenlee, MD

PROBLEM IDENTIFICATION
& DESCRIPTION OF NEED
• Mental illness is prevalent
• ~1-in-5 adults in high-income countries live with mental illness, from common mental disorders (e.g.
major depression, anxiety) to serious mental illnesses (e.g. schizophrenia, bipolar affective disorder) 1

• People with mental illness frequently have high rates of adverse somatic health factors
• Tobacco and other substance use, physical inactivity, and poor diet2
• Iatrogenic effects of many psychotropic medications contributing to higher rates of chronic medical
conditions such as diabetes, cardiovascular disease, and thromboembolic events3

• As a result, mental and physical disorders commonly co-exist, leading to higher morbidity
and mortality in people living with mental illness4
• Such patients have among the greatest needs, but they often receive poorer quality of care
due to a combination of many factors, including both system and provider issues5

PUBLIC HEALTH COST & UNIQUE COST
CONSIDERATIONS IN HOST COMMUNITY
• Research has consistently demonstrated worse clinical outcomes and higher costs of care
for patients with mental illness6,7
• This population has an estimated mortality rate that is 2.2 times higher than the general population 8
• Health care costs are estimated to be 60–75% higher for those with mental illness than those
without9

• State mental health agencies (SMHAs) served ~7.1M clients in FY 2012 at a cost of $39.7B10
• These 7.1M clients represent ~21% of the 34.1M people nationwide receiving some form of mental
health service during FY 201210
• US states are increasingly turning toward their respective SMHAs to meet the mental health needs
of their populations

• An estimated 4.7% of VT’s adult population lives with serious mental illness11
• 57.7% of this population receives any form of treatment from either the public system or private
providers11
• VT Department of Mental Health (DMH) served approximately 7K adult clients in FY 2018 12
• In FY 2013, DMH service expenditure was $182.6M; per capita expenditure, $291.70 13

COMMUNITY PERSPECTIVE ON ISSUE
& SUPPORT FOR PROJECT
• Seven interviews
• Adam R. Greenlee, MD
• double-boarded in Family Medicine & Psychiatry
• Six anonymous patients starting new prescriptions of
second-generation antipsychotics (SGAs)

• Takeaways from interviews
• “Patients living with both medical and psychiatric
illnesses are complex”
• “Psychiatric crises bring patients in, not their medical
issues… Stabilizing [these crises] takes up all of our
time, and medical issues are left unresolved, without
agreed upon plans for follow-up.”
• “What are the side effects?”
• “Is there anything I can do about the side effects?”
• “All of the information is so overwhelming!”
• “A handout would be helpful”

https://www.chcb.org/locations-providers/riverside-health-center/

INTERVENTION & METHODOLOGY
• Drafted & designed an information pamphlet containing
information and instructions for patients starting new SGAs
prescriptions
• Expert medical consultation by Dr. Greenlee
• Art direction & consultation by Kansas City-based artist and graphic
designer Dave Coates

• Pamphlets designed for accessibility –
• “friendly” graphics following line-of-sight principles
• Two versions created –
• English, with hand-lettered font
• Blank template with only graphics, allowing room for typed
translated text

• To better assist medication concordance, follow-up appointment
date & time are highlighted14

RESULTS & RESPONSE DATA
• Created an easy-to-read, clear and
engaging informational pamphlet for
patients
• Included information addresses
common patient concerns:
•
•
•
•

SGAs basics and benefits
Potential side effects
Plans for patient follow-up
Resources for psychiatric crises

• Dr. Greenlee consulted with each
draft iteration

EVALUATION OF
EFFECTIVENESS & LIMITATIONS
• Evaluation
• Encourage in-visit distribution of pamphlet to patients receiving new/updated SGA prescriptions
• Useful evaluations would include:
• Tracking of pamphlet distribution to appropriate patients
• Pamphlet utility, as gauged by patient and provider feedback

• Limitations
• Due to the delayed conception of the project, follow-up, concordance and motivational interviewing
are unable to be followed or assessed at this time
• Two formats printed: English, and blank template for translation via word processor
• Translated versions are reliant upon both accurate translation of technical information and
stakeholder representative access to word processing
• Patients may not be aware of pamphlet

RECOMMENDATIONS FOR
FUTURE INTERVENTIONS & PROJECTS
• Follow-up with patients to assess longitudinal SGA
prescription concordance, rates of complications &
side effects, and outcomes
• For future iterations of informational pamphlets,
canvassing patients for opinions and attitudes on
SGAs would help refine the language used
• If deemed successful and of utility, consider
expanding this series of informational pamphlets to
include other classes of therapeutic psychotropic
agents
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